$LGND 8-K/A SEC Filings

Filed On	Filing
02 Sep 2026	8-K/A: Financial Statements and Exhibits The accompanying notes are an integral part of these condensed consolidated financial statements.
13 Nov 2023	8-K/A: Results of Operations and Financial Condition SAN DIEGO, Calif. (November 8, 2023) – Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2023, and provided an operating forecast and business updates. L...
10 Dec 2020	8-K/A: Financial Statements and Exhibits
06 Dec 2018	8-K/A: Financial Statements and Exhibits
07 Mar 2018	8-K/A: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more
09 May 2016	8-K/A: Entry into a Material Definitive Agreement
22 Mar 2016	8-K/A: Financial Statements and Exhibits
03 Mar 2016	8-K/A: Financial Statements and Exhibits
22 Jan 2013	8-K/A: Departure/Election of Directors or Officers; Compensation
28 Sep 2011	8-K/A: Submission of Matters to a Vote of Security Holders
24 Jun 2011	8-K/A: Regulation FD Disclosure
12 Apr 2011	8-K/A: Completion of Acquisition or Disposition of Assets
11 Apr 2011	8-K/A: Completion of Acquisition or Disposition of Assets
25 Feb 2009	8-K/A: Financial Statements and Exhibits
25 Sep 2008	8-K/A: Entry into a Material Definitive Agreement; Regulation FD Disclosure
31 Aug 2004	8-K/A: Changes in Registrant's Certifying Accountant
25 Aug 2004	8-K/A: Changes in Registrant's Certifying Accountant
25 Sep 1998	8-K/A: Financial Statements and Exhibits

Comments